Basic study towords reconstitution of normal and leukemic human hemopoiesis in small monkey of common marmoset
Basic study towords reconstitution of normal and leukemic human hemopoiesis in small monkey of common marmoset
批准号:
11557073
负责人:
TANI Kenzaburo
金额:
$8.64万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For the purpose of constructing preclinical monkey models with normal and leukemic human hematopoiesis, we have introduced small monkey of common marmoset. The followings are the progress in this year.1) Construction of normal and leukemic human hematopoiesis in marmoset :We transplanted CD34 positive human umbilical cord blood cells intraperitoneally to marmoset fetus under the guide of ultrasonograph. We have so far transplanted the CD34 positive human cord blood cells to 16 fetuses in 8 mother marmosets. We have also transplanted human leukemia cells of BV173, IMS-BC1 or Meg-01 to 14 fetuses in 7 mother marmosets. In the beginning abortions followed by the transplantations were experienced but the techniques have been improved using highly sensitive ultrasonography. Now we are following up carefully the in vivo constitution of human/marmoset chimera hematopoiesis in newborn marmosets.2) Characterization of common marmoset lymphocytes : We have isolated marmoset lymphocyte fractions which were positive for human CD4, CD8 or CD56 monoclonal antibodies. The lymphocytes positive for human CD4 or CD8 antibody were considered also to be functional in marmosets. CD56 positive lymphocytes should furthermore be characterized to elucidate its characters.We have so far demonstrated the similar characters of hematopoietic cells and lymphocytes between human and common marmosets. These findings support the possibility of constructing marmoset with human/marmoset hematopoietic chimera. Such marmosets would be very beneficial to study the safety and efficacy of newly developed gene transfer vectors as well as biological modifiers at preclinical levels. Although we have not successfully constructed such chimera marmosets yet, we have developed several new strategies which would make the xenografting more safely and efficiently. Further experiment is required to construct marmoset preclinical model system to study normal and leukemic human hematopoiesis.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Wu, M-S., Tani, K., Isaki, T., Asano S., et al.: "MHC (Major Histocompatibility Complex)-DRB Genes and Polymorphisms in Common Marmoset."J.Mol Evol. 52. 214-222 (2000)
Wu, M-S.、Tani, K.、Isaki, T.、Asano S. 等人:“普通狨猴中的 MHC(主要组织相容性复合体)-DRB 基因和多态性。”J.Mol Evol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohata,J.,Tani,K.,et al.: "CD4/CD8 double-positive adult T cell leukemia With preceding cytomegaloviral gastroenterocolitis"Int J Hematol.. 69. 1-5 (1999)
Ohata,J.,Tani,K.,et al.:“CD4/CD8 双阳性成人 T 细胞白血病伴有巨细胞病毒性胃肠结肠炎”Int J Hematol.. 69. 1-5 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Watari,K.,Tani,K.,et al.: "Hyperfunction of neutrophils in a BCR/ABL-negative chronic myeloid leukemia : A case report with in vitro studies."Cancer. 89. 551-560 (2000)
Watari,K.,Tani,K.,et al.:“BCR/ABL 阴性慢性粒细胞白血病中的中性粒细胞功能亢进:体外研究的病例报告。”癌症。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada N, Hamada H.et al.: "The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia."J Hum Genet.. 45 (3). 138-41 (2000)
Yamada N、Hamada H.等人:“纤溶酶原激活物抑制剂-1 基因的 4G/5G 多态性与严重先兆子痫相关。”J Hum Genet.. 45 (3)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
谷 憲三郎: "血液悪性腫瘍に対する遺伝子治療"臨床病理. 10 (1999)
Kenzaburo Tani:“血液恶性肿瘤的基因治疗”临床病理学 10 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 30 条
Development of evolutional gene modified T cell transfusion therapy using novel and self-developed measles viral vector
-
批准号:17H01547
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.87万
-
财政年份:2017
-
负责人:TANI Kenzaburo
-
依托单位:
Clinical development of the novel oncolytic coxsackievirus B3 targeting malignant tumors
-
批准号:23240133
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.45万
-
财政年份:2011
-
负责人:TANI Kenzaburo
-
依托单位:
Construction of the system for hematopoietic cell production from human ES cells and the analysis of its molecular basis toward the development of ES cell therapies
-
批准号:20390273
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2008
-
负责人:TANI Kenzaburo
-
依托单位:
Development of new gene therapy vectors and the preclinical cancer animal model system using common marmoset
-
批准号:17016053
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$32.0万
-
财政年份:2005
-
负责人:TANI Kenzaburo
-
依托单位:
Development of efficient hematopoietic stem cell proliferation systems using our own established ES cells of small monkey, common marmoset
-
批准号:17390279
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.86万
-
财政年份:2005
-
负责人:TANI Kenzaburo
-
依托单位:
Elucidation of pathogenic genes for abnormal hematopoiesis and the development of gene therapy in paroxysmal nocturnal hemoglobinuria
-
批准号:14370299
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2002
-
负责人:TANI Kenzaburo
-
依托单位:
Development of new immunogene therapy for refractory leukemia and lymphoma
-
批准号:10470208
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:1998
-
负责人:TANI Kenzaburo
-
依托单位: